| 
			 
			  
			
			 
			 
			
			  
			by Ali Le Vere 
			
			October 
			03, 2019 
			
			from
			
			GreenMedInfo Website 
  
			
			  
			
				
					
						| 
						 
						Ali 
						Le Vere holds dual Bachelor of Science degrees in Human 
						Biology and Psychology, minors in Health Promotion and 
						in Bioethics, Humanities, and Society, and is a Master 
						of Science in Human Nutrition and Functional Medicine 
						candidate.  
						
						
						Having contended with chronic illness, her mission is to 
						educate the public about the transformative potential of 
						therapeutic nutrition and to disseminate information on 
						evidence-based, empirically rooted holistic healing 
						modalities.  
						
						Read 
						more at @empoweredautoimmune on Instagram and at
						
						
						
						https://www.EmpoweredAutoimmune.com: 
						Science-based natural remedies for autoimmune disease, 
						dysautonomia, Lyme disease, and other chronic, 
						inflammatory illnesses.  | 
					 
				 
			 
			
			  
			
			  
			
			  
			
			  
			
			  
			
			  
			
			 
			 
			
			Revolutionary research  
			
			illuminates that 
			a new frontier  
			
			of personalized 
			medicine lies in the virome.  
			
			  
			
			Rather than 
			harbingers of disease,  
			
			viruses are 
			intrinsic to immune modulation  
			
			and to disease 
			susceptibility... 
  
			
			  
			
			 
			
			The microbiota, composed of the 
			thirty-eight trillion bacteria that inhabit the corporeal 
			body, have garnered unprecedented publicity in recent years. 
			(1) 
			
			  
			
			However, unbeknownst to 
			most of the public, mammals are also populated by a staggering host 
			of chronic viruses called
			
			the virome, which elicit significant effects upon disease 
			susceptibility and physiological homeostasis. (2) 
			 
			Ranging from innocuous to potentially lethal, an enormous array of 
			endogenous viral elements, RNA and DNA viruses that infect host 
			cells, and viruses that infect the microbiota are present in all 
			adult humans. (14) 
			
			  
			
			The quantity of viruses 
			present in fecal matter, in fact, rivals that of bacteria, at 
			upwards of one billion viral particles per gram. (3)
			 
			
			  
			
			Many viruses elude 
			annotation, representing novel viruses that are yet to be 
			classified. (4,5) 
			
			  
			
			  
			
			  
			
			 
			Latent or 
			Stealth Infections Enable Viruses to Evade Immune Detection 
			 
			Infection with multiple herpes viruses, for instance, is an 
			inextricable part of the human condition, to which more than 90% of 
			humans are subject. (6)  
			
			  
			
			Because the ancestral 
			herpes viruses infect birds, reptiles, and mammals, pioneering 
			researcher and world-renowned expert in immunology, virology, and 
			infectious disease, Dr.
			
			Herbert W. 
			"Skip" Virgin IV 
			states,  
			
				
				"The herpes viruses 
				have been studying you far longer than you have been studying 
				the herpes viruses". (7) 
			 
			
			In fact, herpes viruses 
			co-evolved down species-specific lines with the speciation of 
			mammals in evolutionary history. (7) 
			 
			Following immune clearance of the primary infection, the herpes 
			virus adopts a dormant state called latency by expressing an 
			alternative gene set which inhibits its central lytic functions, one 
			of the two cycles of viral reproduction. (8)  
			
			  
			
			Latency enables the virus 
			to hide from the immune system and permanently persist within the 
			host. (8) 
			
			  
			
			For example, after acute 
			infection, herpes simplex virus type 1 (HSV-1) replicates in 
			epithelial cells and migrates to the sensory neurons via nerve 
			termini where it enters a latent phase in its stronghold, the 
			trigeminal ganglion in the dura mater. (8,9) 
			 
			Latency, which was formerly considered to be a parasitic state, 
			renders the host vulnerable to subsequent reactivation of the virus 
			and secondary infections at peripheral sites. (8)  
			
			  
			
			Recurrent episodes of 
			infection, ranging from cold sores to eyesight-threatening ocular 
			herpes and neurological herpes encephalitis can occur with 
			successive viral re-activations. (9)  
			
			  
			
			As articulated by Aranda 
			and Epstein (2015),  
			
				
				"Latency is an 
				adaptive phenotype that allows the virus to escape immune host 
				responses and to reactivate and disseminate to other hosts upon 
				recognizing danger signals such as stress, neurologic trauma or 
				growth factor deprivation". (8, p. 506) 
			 
			
			  
			
			  
			
			 
			The Virome 
			Protects Against Bacterial Infection 
			 
			In a paradigm-shifting revision, however, researchers discovered 
			that latency may confer health benefits for the host.  
			
			  
			
			Barton and colleagues 
			(2007) found that mice that harbored latent infections with 
			murine gammaherpesvirus 68 or murine cytomegalovirus, genetic 
			analogs to human pathogens Epstein-Barr virus (the causative agent 
			behind mononucleosis, or the "kissing disease") and human 
			cytomegalovirus (CMV), respectively, were resistant to bacterial 
			infection by Listeria monocytogenes and Yersinia pestis.
			(10) 
			 
			The mechanism whereby this occurred was by virally-stimulated 
			up-regulation of the antiviral cytokine interferon-gamma (IFNγ). 
			(10)  
			
			  
			
			In turn, IFNγ created 
			systemic activation of macrophages, a cell subset which are vital to 
			the non-specific, innate immune defenses which are first deployed on 
			the scene of pathogen invasion and can curtail bacterial 
			infectivity. (10) 
			 
			Infection with a chronic virus effectively "upregulates the basal 
			activation state of innate immunity against subsequent infections" 
			and "may also sculpt the immune response to self and environmental 
			antigens through establishment of a polarized cytokine environment".
			(10, p. 326) 
			 
			Therefore, rather than being completely pathogenic,  
			
				
				"our data suggest 
				that latency is a symbiotic relationship with immune benefits 
				for the host". (10) 
			 
			
			  
			
			  
			
			 
			The Virome 
			Alters Disease Susceptibility 
			 
			In genetically susceptible individuals, viruses can modify risk for 
			chronic disease.  
			
			  
			
			For instance, lymphocytic 
			choriomeningitis virus (LCMV) can inhibit development of diabetes in 
			rodent models, whereas it exacerbates glomerulonephritis, or acute 
			inflammation of the kidney, in certain inbred populations. (11)
			 
			
			  
			
			In those with 
			abnormalities in genes related to viral recognition, including 
			toll-like receptor 7 (TLR7) and TLR9, early life infection with 
			severe rhinovirus (the common cold) is strongly implicated in 
			development of asthma. (12, 13) 
			 
			Epstein-Barr virus (EBV) levels are enriched in autoimmune patients 
			with rheumatoid arthritis (RA), Sjogren's syndrome, systemic lupus 
			erythematous (SLE), and multiple sclerosis (MS). (14)
			 
			
			  
			
			Researchers speculate 
			that chronic EBV infection could incite autoimmune disorders through 
			mechanisms including molecular mimicry (the immune response becomes 
			misdirected against self) or the bystander effect (self-tissues 
			become caught in the cross-fire). (15,16) 
			 
			Another virus which alters disease risk is norovirus, a virus which 
			is culpable for the vast majority of epidemic non-bacterial episodes 
			of gastroenteritis (stomach flu) in humans. (17)  
			
			  
			
			For instance, in mice 
			harboring a mutation in the autophagy gene Atg16L1, which enhances 
			predisposition to Crohn's disease, intestinal pathology was induced 
			when murine norovirus infection was present. (11)  
			
			  
			
			When mice with the 
			Atg16L1 mutation and murine norovirus were administered the toxic 
			substance dextran sodium sulfate (DSS), which induces inflammatory 
			bowel disease, there was an increased amount of DSS-induced colitis 
			as well as the presence of DSS-induced villus atrophy signifying 
			enhanced intestinal damage in a manner resembling Crohn's disease.
			(11) 
			 
			In concert with the susceptibility gene, the virus induced 
			aberrations in granule packaging in ileal Paneth cells, a 
			specialized intestinal epithelial cell that secretes granules 
			containing antimicrobial peptides and lysozyme, contents which 
			change the intestinal environment. (11,18)  
			
			  
			
			These same Paneth cell 
			abnormalities were observed in humans with the Atg16L1 mutation, 
			which means that presumably norovirus could trigger Crohn's disease 
			expression in humans with this genetic propensity as well. 
			 
			In addition, the combination of the virus plus the gene mutation led 
			to a distinct profile of gene transcription.  
			
			  
			
			The authors conclude that 
			the, 
			
				
				"virus-plus- 
				susceptibility gene interaction can, in combination with 
				additional environmental factors and commensal bacteria, 
				determine the phenotype of hosts carrying common risk alleles 
				for inflammatory disease". (11, p. 1135)  
			 
			
			Stated differently, 
			viruses can trigger disease onset in genetically vulnerable hosts. 
			
			  
			
			  
			
			  
			
			 
			The Virome 
			Changes Genetic Expression and Autoimmune Risk  
			 
			In the aforementioned study, the presence of the murine norovirus 
			led to substantial changes in gene expression in the Atg16L1-mutant 
			animals compared to the wild-type (normal) animals. (11)
			 
			
			  
			
			For instance, there were 
			complete inversions in the levels of expression for genes regulating 
			carbohydrate and amino acid metabolism, intracellular protein 
			traffic, and protein targeting and localization, indicating that 
			genetic vulnerabilities may determine the way that viral infections 
			influence our transcriptional identity. (11) 
			 
			These alterations in gene expression may elicit significant effects 
			on the immunophenotype of the host.  
			
			  
			
			The immunophenotype is 
			the basal level of activation of the immune system upon challenge 
			with antigens, or immunogenic material against which an immune 
			response is directed. (19)  
			
			  
			
			Thus, changes in gene 
			expression due to chronic viral infection may influence the way the 
			immune system responds to future pathogenic invaders. 
			 
			Differential expression of genes in response to viral infection may 
			also influence susceptibility to and progression of chronic disease 
			pathogenesis. (19)  
			
			  
			
			Latent infection with 
			gammaherpesvirus 68 in mice has been shown to produce differential 
			expression of genes in the spleen, brain, and liver, leading to 
			marked changes in the transcriptional status of organs of the host.
			(19)  
			
			  
			
			Most modifications in 
			gene expression occurred to immune-related genes, and in particular, 
			it was demonstrated that latent viruses regulated expression of 
			genes that conferred risk for autoimmune disorders including celiac 
			disease, Crohn's disease, and multiple sclerosis. (7,19) 
			
			  
			
			  
			
			  
			
			 
			Viral 
			Infection Complements Immunodeficiency 
			 
			Mutations in the Hoil-1 gene produce a disorder of both 
			immunodeficiency and chronic inflammation, which renders people with 
			risk alleles extremely susceptible to bacterial infections. (7)
			 
			
			  
			
			In order to examine the 
			implications of this mutation, MacDuff et al. (2015) studied mice 
			with equivalent mutations, which died when infected by certain 
			bacteria and parasites including, 
			
				
					- 
					
					Listeria 
					monocytogenes  
					- 
					
					Toxoplasma gondii 
					 
					- 
					
					Citrobacter 
					rodentium,  
				 
			 
			
			...due to impaired 
			production of pro-inflammatory cytokines that are required for 
			resistance to these pathogens. (20) 
			 
			However, researchers state that latent murine herpesvirus 68 
			infection, 
			
				
				"rescued HOIL-1 
				deficient mice from lethality during Listeria infection and 
				induced high levels of the protective cytokine, interferon-gamma 
				(IFNγ)". (20, p. 3)  
			 
			
			IFNγ is a cytokine which 
			the body produces upon viral exposure, which promotes neutralization 
			of viruses with antibodies and killing of virally-infected cells by 
			immune cells called cytotoxic T lymphocytes and natural killer (NK) 
			cells. (20) 
			 
			Therefore, this virally-induced IFNγ production leads to a form of 
			immunomodulation which can protect the host from bacterial 
			infection. 
			 
			Likewise, in mice with genetic mutations in immune-related genes 
			encoding proteins for interleukin-6, an inflammatory intercellular 
			signaling molecule, and caspases-1 and caspase-11, enzymes which 
			function in programmed cell death, chronic herpesvirus infection 
			dramatically protected these immunodeficient mice from Listeria 
			monocytogenes infection. (20)  
			
			  
			
			In other words,  
			
				
				"chronic herpesvirus 
				infection stimulates the immune system, and so allows it to 
				compensate for the lack of cytokine production associated with 
				various immunodeficiencies". (20, p. 2) 
			 
			
			Differences in viral 
			elements may account for why people with the same genetic 
			predilection have vastly different clinical presentations.  
			
			  
			
			This is another example 
			of how genes should not be equated with destiny, as expression of 
			genetic mutations is influenced by environmental triggers, including 
			viral elements.  
			
			  
			
			Thus, it is possible that 
			infection with latent viruses, which develop a symbiotic 
			relationship with the host, may be a future therapeutic strategy for 
			favorably changing the clinical presentations of particular 
			immunodeficiency-related genetic disorders. 
			
			  
			
			  
			
			  
			
			 
			Other 
			Commensal Microbes Influence Viral Pathology 
			 
			Researcher Herbert W. "Skip" Virgin IV and his 
			colleagues developed the hypothesis that viral immunity and viral 
			pathogenesis would be governed by ‘transkingdom metagenomic 
			interactions'. (7)  
			
			  
			
			In other words, the 
			interplay between all genetic sequences in or on the host, from 
			either human genetic material or commensal microorganisms residing 
			within the human body, would dictate the course of a viral 
			infection. 
			 
			
			Helminths, for example, which are 
			parasitic worms that infect mammals, can promote viral replication 
			by both inhibiting the antiviral effects of the cytokine 
			interferon-γ (IFNγ) and by inducing production of the cytokine 
			interleukin-4 (IL-4), both of which culminate in reactivation of the 
			murine γ-herpesvirus infection. (6)  
			
			  
			
			The helminth likewise 
			activates the transcription factor Stat6, which elicits downstream 
			changes that induce viruses to move from a latency phase to active 
			infection. (6)  
			
			  
			
			In this instance, the 
			virus senses and responds to the immunological milieu of the host, 
			which is influenced by the helminth. 
			 
			
			Norovirus, the most prevalent cause 
			of acute infectious gastroenteritis, is another example of a virus 
			that can latently infect the human intestine. (22)  
			
			  
			
			In fact, norovirus is 
			present in 21% of people with immune deficiencies and is 
			asymptomatically shed in the feces of 3-17% of humans, which can 
			lead to the chronic norovirus epidemics. (23) 
			 
			Norovirus represents another example of a transkingdom interaction, 
			as the bacterial microbiota in the gut can foster viral persistence 
			of this viral subtype. This phenomenon was demonstrated by an 
			experiment where antibiotic administration, which presumably 
			decimated the microbiota, prevented persistent murine norovirus (MNoV) 
			infection. (24)  
			
			  
			
			However, restoration of 
			the microbiota with a fecal transplant reversed the inhibition of 
			persistent intestinal norovirus infection and led to viral 
			reactivation in the lymph nodes, ileum, and colon as well as viral 
			shedding in the stool. (24) 
			 
			The enteric microbiota, at a mechanistic level, can perpetuate the 
			infectivity of viruses by, 
			
				
				"the direct 
				facilitation of viral infection, including bacterial 
				stabilization of viral particles and the facilitation of viral 
				attachment to host target cells; and the indirect skewing of the 
				antiviral immune response in a manner that promotes viral 
				infection". (25, p. 197) 
			 
			
			The effect of
			
			the microbiota on the viral 
			infection, however, is mediated by the host immune system, and 
			certain immune-related genes are required for the 
			antibiotic-mediated suppression of the viral response.  
			
			  
			
			This is illustrated by 
			data showing that with mice who were genetically manipulated to be 
			deficient in certain genes, such as interferon-gamma, the 
			antibiotics had no effect on decreasing viral persistence. (24)
			 
			
			  
			
			Interferon-lambda, or 
			type III interferon, a cytokine which is used to treat hepatitis C 
			in humans, can both prevent establishment of persistent infection 
			with intestinal norovirus and can cure persistent viral infection.
			(26) 
			 
			These examples represent evolutionarily conserved interactions 
			between organisms of divergent kingdoms, such as bacteria and 
			parasites, along with host molecules such as interferon, which 
			influence the infectivity of chronic viruses. 
			
			  
			
			  
			
			  
			
			 
			Virome 
			Alterations are Related to Autoimmune and Inflammatory Diseases 
			 
			In a multi-center clinical study, researchers analyzed the viromes 
			of cohorts with inflammatory bowel disease (IBD) compared to 
			household controls. (27)  
			
			  
			
			It is well-established 
			that patients with
			
			Crohn's disease and ulcerative 
			colitis have diminished species richness and phylogenetic diversity 
			in their gut microflora compared to healthy cohorts. (27)
			 
			
			  
			
			However, when their 
			viromes were sequenced, increased numbers of
			
			bacteriophages, or viruses that 
			infect and multiply within bacteria, were found in the IBD 
			populations. (27) 
			 
			In particular, signature bacteriophages were found to be IBD-subtype 
			specific, with different viruses appearing in ulcerative colitis 
			versus Crohn's disease. (27)  
			
			  
			
			In addition, a 
			significant expansion of Caudovirales bacteriophages was 
			observed in both ulcerative colitis and Crohn's disease. (27)
			 
			
			  
			
			Rather than virome 
			changes occurring secondarily to microbiome changes, researchers 
			speculate that a predator-prey relationship exists between the 
			virome and microbiome. (7)  
			
			  
			
			Within this paradigm, 
			bacteriophage introduction changes the microbiome, shifting to a new 
			equilibrium state of enhanced disease vulnerability. (7)
			 
			
			  
			
			The researchers conclude 
			that,  
			
				
				"These data support a 
				model in which changes in the virome may contribute to 
				intestinal inflammation and bacterial dysbiosis… the virome is a 
				candidate for contributing to, or being a biomarker for, human 
				inflammatory bowel disease and [we] speculate that the enteric 
				virome may play a role in other diseases". (27, p. 447) 
			 
			
			Not only will this body 
			of literature have implications for other disorders in which 
			microbial dysbiosis, or bacterial imbalance, plays a role, but it 
			also paves the way for the development of condition-specific 
			probiotics and even provirotics, or viruses that elicit beneficial 
			effects on the host. 
			
			  
			
			It also raises questions 
			about the utility of probiotics already on the market, which may 
			fall victim to infection with bacteriophages when ingested by the 
			host, which could theoretically exacerbate some conditions. 
			
			  
			
			  
			
			  
			
			 
			Future 
			Implications of the Virome 
			 
			In summary, when examining the relationship between the genotype, or 
			the genetic constitution of an organism, and the phenotype, or the 
			observable characteristics resulting from the interaction between 
			genes and environment, the virome must be taken into account. 
			(7)  
			
			  
			
			In the meta-genome, there 
			are layers of interactions between bacteria, parasites, viruses, and 
			host physiology, which can influence disease risk. (7) 
			 
			Viruses are essential to the convoluted and dynamic network of 
			microorganisms that reside within the body. (14)  
			
			  
			
			Early life infection with 
			certain viruses has even been demonstrated to change the expression 
			of genes related to vaccine responses in both mice and humans, 
			(7) which may account for why some individuals are more 
			susceptible to vaccine injury than others. 
			 
			Further, vaccinations may deprive the body of favorable 
			immune-modulating effects of some viral infections.  
			
			  
			
			Contrary to the dualistic 
			view of Western medicine, most viruses are neither innately good 
			nor bad, as, 
			
				
				"one virus could have 
				multiple adverse and beneficial immunomodulatory effects on the 
				host that are dependent on the anatomical location, host 
				genotype, and the presence of other infectious agents and 
				commensal microbes". (14)  
			 
			
			This confirms what 
			Louis Pasteur, the father of immunization and pasteurization 
			himself, admitted on his death bed:  
			
				
				that it is the 
				biochemical context and physiological milieu that matters, 
				rather than the infecting pathogen (Tracey, 2017). 
			 
			
			This research represents 
			a fundamental revisioning of what it means to be human, and an 
			expansion upon Stanford's Dr. Justin Sonnenberg's hypothesis 
			that humans may merely be elaborate vessels designed for the 
			propagation of bacterial colonies.  
			
			  
			
			Human physiology and 
			genetic expression is influenced by an amalgamation of organisms 
			transcending phylogenetic designations.  
			
			  
			
			Because this field is 
			still in its infancy, the virome represents uncharted terrain and an 
			unexplored opportunity to delineate how viruses favorably and 
			unfavorably modulate human biology. 
  
			
			  
			
			  
			
			 
			References 
			
				
				1. Sender, R., Fuchs, 
				S., & Milo, R. (2016). Revisited estimates for the number of 
				human and bacterial cells in the body. PLOS Biology, 14(6), 
				e1002533. 
				 
				2. Virgin, H.W. (2014). The Virome in Mammalian Physiology and 
				Disease. Cell, 157, 142-150. 
				 
				3. Kim, M.S. et al. (2011). Diversity and abundance of 
				single-stranded DNA viruses in human feces. Applied and 
				Environmental Microbiology, 77, 8062–8070. 
				 
				4. Finkbeiner, S.R. et al. (2008). Metagenomic analysis of human 
				diarrhea: viral detection and discovery. PLoS Pathology, 4, 
				e1000011. 
				 
				Originally published: 2017-09-08  
				 
				Article updated: 2019-10-03 
				 
				5. Firth, C. et al. (2014). Detection of zoonotic pathogens and 
				characterization of novel viruses carried by commensal Rattus 
				norvegicus in New York City. mBio, 5, e01933–01914. 
				 
				6. Reese, T.A. et al. (2014). Helminth infection reactivates 
				latent γ-herpesvirus via cytokine competition at a viral 
				promoter. Science, 345(6196), 573-577. doi: 
				10.1126/science.1254517. 
				 
				7. NIH Center for Information and Technology. [nihvcast]. 
				(2015). The mammalian virome in genetic analysis of health and 
				disease pathogenesis. Retrieved from
				
				
				https://www.youtube.com/watch?v=TRVxTBuvChU  
				 
				8. Aranda, A.M., & Epstein, A.L. (2015). [Herpes simplex 
				virus type 1 latency and reactivation: an update] [Article in 
				French]. Medical Science (Paris), 31(5), 506-514. [Herpes 
				simplex virus type 1 latency and reactivation: an update]. 
				 
				9. Held, K., & Derfuss, T. (2011). Control of HSV-1 latency 
				in human trigeminal ganglia-- current overview. Journal of 
				Neurovirology, 17(6), 518-527. doi: 10.1007/s13365-011- 0063-0 
				 
				10. Barton, E.S. et al. (2007). Herpesvirus latency confers 
				symbiotic protection from bacterial infection. Nature, 
				447(7142), 326-329. 
				 
				11. Cadwell, K. et al. (2010). Virus-plus- susceptibility gene 
				interaction determines Crohn's disease gene Atg16L1 
				phenotypes in intestine. Cell, 141(7), 1135-1145. doi: 
				10.1016/j.cell.2010.05.009. 
				 
				12. Bartlett, N.W. et al. (2009). Genetics and epidemiology: 
				asthma and infection. Current Opinion in Allergy and Clinical 
				Immunology, 9, 395–400. 
				 
				13. Foxman, E.F., & Iwasaki, A. (2011). Genome-virome 
				interactions: examining the role of common viral infections in 
				complex disease. Nature Reviews Microbiology, 9, 254–264. 
				 
				14. Cadwell, K. et al. (2015). The virome in host health and 
				disease. Immunity, 42(5), 805-813. 
				 
				15. Draborg, A.H., Duus, K., & Houen, G. (2013). 
				Epstein-Barr virus in systemic autoimmune diseases. Clinical 
				& developmental immunology, 35738. 
				 
				16. Munz, C. et al. (2009). Antiviral immune responses: triggers 
				of or triggered by autoimmunity? Nature Reviews Immunology, 9, 
				246–258. 
				 
				17. Mead, P.S. et al. (1999). Food-related illness and death in 
				the United States. Emerging Infectious Diseases, 5, 607-625. 
				 
				18. Cadwell, K. et al. (2008). A key role for autophagy and the 
				autophagy gene Atg16l1 in mouse and human intestinal Paneth 
				cells. Nature, 456(7219), 259-263. doi: 10.1038/nature07416 
				 
				19. Canny, S.P. et al. (2013). Latent gammaherpesvirus 68 
				infection induces distinct transcriptional changes in different 
				organs. Journal of Virology, 88, 730-738. 
				 
				20. MacDuff, D.A. et al. (2015). Phenotypic complementation of 
				genetic immunodeficiency by chronic herpesvirus infection. eLIFE, 
				4, e4494. 
				 
				21. Takeuchi, O., & Akira, S. (2009). Innate immunity to 
				virus infection. Immunological Reviews, 227, 75–86. 
				 
				22. Teunis, P.F. et al. (2015). Shedding of norovirus in 
				symptomatic and asymptomatic infections. Epidemiology of 
				Infection, 143(8), 1710-1717. doi: 10.1017/S095026881400274X. 
				 
				23. Bok, K. et al. (2016). Epidemiology of Norovirus Infection 
				Among Immunocompromised Patients at a Tertiary Care Research 
				Hospital, 2010–2013. Open Forum on Infectious disease, 3(3), 
				ofw169. doi: 10.1093/ofid/ofw169 
				 
				24. Baldridge, M.T. et al. (2015). Commensal microbes and 
				interferon-λ determine persistence of enteric murine norovirus 
				infection. Science, 347(6219), 266-269. doi: 
				10.1126/science.1258025 
				 
				25. Karst, S.M. et al. (2016). The influence of commensal 
				bacteria on infection with enteric viruses. Nature Reviews 
				Microbiology, 13, 197-204. doi:10.1038/nrmicro.2015.25 
				 
				26. Nice, T.J. et al. (2015). Interferon-λ cures persistent 
				murine norovirus infection in the absence of adaptive immunity. 
				Science, 6219, 269-273. doi: 10.1126/science.1258100. 
				 
				27. Norman, J.M. et al. (2015). Disease-specific alterations in 
				the enteric virome in inflammatory bowel disease. Cell, 160(3), 
				447-460. doi: 10.1016/j.cell.2015.01.002. 
				 
				28. Tracey, K.J. (2017). The inflammatory reflex. Nature, 420, 
				853–859. 
			 
			
			  
			
			
			  
	 |